SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.05B
Enterprise Value 3748.98M
Trailing P/E N/A
Forward P/E 1-5.50
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)9.59
Price/Book (mrq)3.86
Enterprise Value/Revenue 36.85
Enterprise Value/EBITDA 6-6.81

Trading Information

Stock Price History

Beta (3Y Monthly) 3.55
52-Week Change 3-54.50%
S&P500 52-Week Change 34.18%
52 Week High 321.80
52 Week Low 36.22
50-Day Moving Average 37.80
200-Day Moving Average 38.77

Share Statistics

Avg Vol (3 month) 3747.17k
Avg Vol (10 day) 3968.83k
Shares Outstanding 5112.86M
Float 104.76M
% Held by Insiders 110.19%
% Held by Institutions 180.12%
Shares Short (Aug 15, 2019) 49.7M
Short Ratio (Aug 15, 2019) 413.43
Short % of Float (Aug 15, 2019) 410.33%
Short % of Shares Outstanding (Aug 15, 2019) 48.59%
Shares Short (prior month Jul 15, 2019) 49.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 28, 2012
Ex-Dividend Date 4Dec 18, 2012
Last Split Factor (new per old) 225/1
Last Split Date 3Sep 6, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin -151.36%
Operating Margin (ttm)-126.64%

Management Effectiveness

Return on Assets (ttm)-21.99%
Return on Equity (ttm)-61.56%

Income Statement

Revenue (ttm)109.33M
Revenue Per Share (ttm)1.02
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)82.58M
EBITDA -110.01M
Net Income Avi to Common (ttm)-184.34M
Diluted EPS (ttm)-1.55
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)288.93M
Total Cash Per Share (mrq)2.6
Total Debt (mrq)4.07M
Total Debt/Equity (mrq)1.60
Current Ratio (mrq)5.37
Book Value Per Share (mrq)2.30

Cash Flow Statement

Operating Cash Flow (ttm)-99.5M
Levered Free Cash Flow (ttm)-16.86M